210 related articles for article (PubMed ID: 29222701)
1. SNF5 as a prognostic factor in skull base chordoma.
Li M; Zhai Y; Bai J; Wang S; Gao H; Li C; Gui S; Du J; Zhang Y
J Neurooncol; 2018 Mar; 137(1):139-146. PubMed ID: 29222701
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma.
Zhang S; Bai J; Li M; Zhai Y; Wang S; Liu Q; Li C; Gui S; Zhang Y
World Neurosurg; 2019 Sep; 129():e199-e206. PubMed ID: 31125781
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical factors and PDGFR-β in predicting prognosis of patients with clival chordoma.
Zhai Y; Bai J; Wang S; Gao H; Li M; Li C; Gui S; Zhang Y
J Neurosurg; 2018 Dec; 129(6):1429-1437. PubMed ID: 29303447
[TBL] [Abstract][Full Text] [Related]
4. Factors for tumor progression in patients with skull base chordoma.
Wang L; Tian K; Wang K; Ma J; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J
Cancer Med; 2016 Sep; 5(9):2368-77. PubMed ID: 27546605
[TBL] [Abstract][Full Text] [Related]
5. Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas.
Wang K; Tian K; Wang L; Wu Z; Ren C; Hao S; Feng J; Li J; Wan H; Jia G; Zhang L; Zhang J
Mol Med Rep; 2015 Sep; 12(3):4298-4304. PubMed ID: 26099340
[TBL] [Abstract][Full Text] [Related]
6. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
[TBL] [Abstract][Full Text] [Related]
7. Male sex as a risk factor for the clinical course of skull base chordomas.
Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
[TBL] [Abstract][Full Text] [Related]
8. C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.
Luo P; Wang X; Zhou J; Li L; Jing Z
Hum Pathol; 2018 Apr; 74():129-134. PubMed ID: 29317233
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors in Skull Base Chordoma: A Systematic Literature Review and Meta-Analysis.
Zou MX; Lv GH; Zhang QS; Wang SF; Li J; Wang XB
World Neurosurg; 2018 Jan; 109():307-327. PubMed ID: 29045855
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors in Clival Chordomas: An Integrated Analysis of 347 Patients.
Zou Y; Neale N; Sun J; Yang M; Bai HX; Tang L; Zhang Z; Landi A; Wang Y; Huang RY; Zhang PJ; Li X; Xiao B; Yang L
World Neurosurg; 2018 Oct; 118():e375-e387. PubMed ID: 29969746
[TBL] [Abstract][Full Text] [Related]
11. Whole-transcriptome analysis of chordoma of the skull base.
Bell D; Raza SM; Bell AH; Fuller GN; DeMonte F
Virchows Arch; 2016 Oct; 469(4):439-49. PubMed ID: 27401718
[TBL] [Abstract][Full Text] [Related]
12. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
Oakley GJ; Fuhrer K; Seethala RR
Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas.
Ouyang T; Zhang N; Zhang Y; Jiao J; Ren J; Huang T; Chen J
World Neurosurg; 2014; 81(5-6):790-7. PubMed ID: 23298670
[TBL] [Abstract][Full Text] [Related]
14. Proposal and Validation of a Basic Progression Scoring System for Patients with Skull Base Chordoma.
Ma JP; Tian KB; Wang L; Wang K; Li D; Yang Y; Du J; Ru XJ; Zhang LW; Wu Z; Zhang JT
World Neurosurg; 2016 Jul; 91():409-18. PubMed ID: 27132181
[TBL] [Abstract][Full Text] [Related]
15. Differences in Dural Penetration of Clival Chordomas Are Associated with Different Prognosis and Expression of Platelet-Derived Growth Factor Receptor-β.
Zhai Y; Bai J; Wang S; Du J; Wang J; Li C; Gui S; Zhang Y
World Neurosurg; 2017 Feb; 98():288-295. PubMed ID: 27506406
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
Lee IJ; Lee RJ; Fahim DK
World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
[TBL] [Abstract][Full Text] [Related]
17. Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma.
Teng C; Yang Q; Xiong Z; Ye N; Li X
Front Surg; 2021; 8():764329. PubMed ID: 34888345
[No Abstract] [Full Text] [Related]
18. Expression of Cathepsin K in Skull Base Chordoma.
Tian K; Ma J; Wang L; Wang K; Li D; Hao S; Yang Y; Du J; Jia G; Zhang L; Wu Z; Zhang J
World Neurosurg; 2017 May; 101():396-404. PubMed ID: 28216213
[TBL] [Abstract][Full Text] [Related]
19. The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma.
Tosuner Z; Bozkurt SU; Kiliç T; Yilmaz B
Turk Patoloji Derg; 2017; 33(2):112-120. PubMed ID: 28272674
[TBL] [Abstract][Full Text] [Related]
20. Presentation, Treatment, and Long-Term Outcome of Intrasellar Chordoma: A Pooled Analysis of Institutional, SEER (Surveillance Epidemiology and End Results), and Published Data.
Ahmed AK; Dawood HY; Arnaout OM; Laws ER; Smith TR
World Neurosurg; 2018 Jan; 109():e676-e683. PubMed ID: 29061463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
